Lexicon: Q4 Earnings Snapshot
In this article:
THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Lexicon Pharmaceuticals Inc. (LXRX) on Monday reported a loss of $48.2 million in its fourth quarter.
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 20 cents.
The drugmaker posted revenue of $702,000 in the period.
For the year, the company reported a loss of $175.6 million, or 79 cents per share. Revenue was reported as $1.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LXRX at https://www.zacks.com/ap/LXRX
